PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Sees Large Increase in Short Interest

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) saw a significant growth in short interest in July. As of July 31st, there was short interest totaling 61,730 shares, a growth of 208.7% from the July 15th total of 20,000 shares. Based on an average daily trading volume, of 228,548 shares, the short-interest ratio is currently 0.3 days.

PharmaTher Price Performance

PharmaTher stock traded up $0.00 during midday trading on Thursday, reaching $0.04. 641,010 shares of the stock traded hands, compared to its average volume of 163,204. The stock’s fifty day moving average is $0.04 and its 200-day moving average is $0.05. PharmaTher has a 12 month low of $0.03 and a 12 month high of $0.39.

PharmaTher Company Profile

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.